Bliss GVS Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bliss GVS Pharma Ltd. on BSE

Load latest

Bliss GVS Pharma Ltd.

04 Oct 2024

151.59

-0.58%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Please find enclosed herewith a certificate received from Link Intime Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2024.

pdf

Bliss GVS Pharma Ltd.

04 Oct 2024

151.59

-0.58%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We like to inform you that the ESOP Allotment Committee of the Company at its meeting held on October 04, 2024, has approved the allotment of 1,57,550 equity shares of the face value of Re.1/-each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ("Bliss GVS ESOP-2019").

pdf

Bliss GVS Pharma Ltd.

30 Sep 2024

151.59

-0.58%

SAST

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

BSE India

Intimation of Closure of the Trading Window is attached.

pdf

Bliss GVS Pharma Ltd.

18 Sep 2024

151.59

-0.58%

Corp. Note

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Enclosed herewith the details of loss of share certificate.

pdf

Bliss GVS Pharma Ltd.

12 Sep 2024

151.59

-0.58%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We like to inform you that the ESOP Allotment Committee of the Company at its meeting held on September 12, 2024, has approved the allotment of 1,14,750 equity shares of the face value of Re.1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma -Employee Stock Option Plan 2019 (''Bliss GVS ESOP-2019'').

pdf

Bliss GVS Pharma Ltd.

27 Aug 2024

151.59

-0.58%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation of Completion of Term of Mr. Subramanian Ramaswamy Vaidya (DIN: 03600249) as an Independent Director of the Company.

pdf

Bliss GVS Pharma Ltd.

27 Aug 2024

151.59

-0.58%

Corp. Note

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Enclosed herewith the details of loss of share certificates.

pdf

Bliss GVS Pharma Ltd.

22 Aug 2024

151.59

-0.58%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the company has received letters via email from the Stock Exchanges dated August 21, 2024 have each imposed a fine on the Company for non-compliance with Regulation 17(1A) of the SEBI Listing Regulations. Please be informed that the Company is actively addressing this issue by applying for a waiver and even appleaing to the appropriate appellate authority, if required.

pdf

Bliss GVS Pharma Ltd.

14 Aug 2024, 07:06PM

151.59

-0.58%

Company Update

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We like to inform you that the ESOP Committee of the Company at its meeting held on August 14, 2024, has approved the allotment of 64,150 equity shares of the face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019 ("Bliss GVS ESOP-2019")

pdf

Bliss GVS Pharma Ltd.

14 Aug 2024, 06:26PM

151.59

-0.58%

Corp. Note

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Enclosed herewith the details of loss of share certificate.

pdf

Is Bliss GVS Pharma Ltd. worth buying?

169 Votes:

Buy 81.07%

Sell 8.88%

Hold 10.06%